Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.18 USD | -1.10% | +3.68% | -5.54% |
Jun. 05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
Jun. 05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.54% | 3.57B | |
+2.22% | 93.53B | |
-1.71% | 38.27B | |
-12.83% | 32.84B | |
-12.14% | 16.08B | |
-0.68% | 14.02B | |
-12.63% | 11.47B | |
+163.45% | 9.92B | |
-53.23% | 9.42B | |
+3.52% | 8.98B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Transcript : Axsome Therapeutics, Inc., Q4 2021 Earnings Call, Mar 01, 2022